Лучшие больницы для «Mole Removal» в Бангалор, Индия

A mole (melanocytic nevus) is a benign proliferation of melanocytes — the pigment-producing cells of the skin — that can be present at birth (congenital nevi) or develop throughout life in response to UV exposure, hormonal changes, or genetic predisposition. The vast majority of moles are clinically benign; however, a subset — particularly dysplastic (atypical) nevi, large congenital nevi, or lesions demonstrating the ABCDE criteria (Asymmetry, irregular Border, multiple Colours, Diameter >6 mm, Evolution) — carry an elevated risk of malignant transformation into melanoma, one of the most aggressive skin cancers. Dermatoscopic evaluation using polarised-light dermoscopy and, where indicated, reflectance confocal microscopy (RCM) allows clinicians to stratify lesions non-invasively before any incision is planned.

• ELIGIBLE CANDIDATES:
• Patients with a mole exhibiting one or more ABCDE warning signs (Asymmetry, Border irregularity, Colour variegation, Diameter >6 mm, Evolution/change over time)
• Individuals with dysplastic (Clark's) nevi confirmed on dermoscopy or prior biopsy, particularly those with a personal or family history of melanoma
• Patients with congenital melanocytic nevi, especially giant congenital nevi (GCN >20 cm), which carry a lifetime melanoma transformation risk of 5–10%
• Cosmetically bothersome raised, pigmented, or repeatedly traumatised moles causing physical discomfort (e.g., snagging on clothing, recurrent bleeding)
• +16 more

Standard APPROACHES:

1. SURGICAL EXCISION WITH PRIMARY CLOSURE (Gold Standard for Atypical or Suspicious Nevi) The most oncologically sound method. Under local anaesthesia (1–2% lidocaine with 1:100,000 adrenaline), an elliptical excision is planned along Langer's lines of skin tension to ensure a cosmetically optimal scar orientation. Margins of 2 mm are used for clinically benign lesions; 5 mm for dysplastic nevi; and up to 1 cm for in situ melanoma (per NICE NG14 guidelines if malignancy is confirmed post-biopsy). Deep closure uses interrupted 3-0 or 4-0 absorbable Monocryl sutures to eliminate dead space and reduce wound tension; skin closure is with 5-0 or 6-0 Prolene or Ethilon, or alternatively Steri-Strip closure with tissue adhesive (Dermabond). Sutures are removed at 5–7 days (face) or 10–14 days (body). All specimens undergo formal histopathological review with margin assessment.

2. SHAVE EXCISION (For Raised, Benign, Intradermal Nevi) Using a DermaBlade or surgical scalpel angled at 15–30°, the raised portion of the mole is shaved flush with the surrounding skin surface. A shallow horizontal incision removes the bulk of the lesion without entering the deep dermis, minimising the risk of a linear scar. Haemostasis is achieved with aluminium chloride 20% solution or light electrocautery. This technique produces a flat, circular wound that heals by secondary intention over 2–4 weeks, typically with an excellent cosmetic result for dome-shaped intradermal nevi. Specimen histopathology is still mandatory to exclude unexpected dysplasia.

3. PUNCH EXCISION (For Small Nevi ≤6 mm) A circular punch biopsy tool (2–6 mm diameter) is used to core out small, well-defined moles in a single-step excise-and-biopsy procedure. The resulting circular defect is closed with 1–2 interrupted sutures or left to heal by secondary intention for very small defects. Punch excision offers speed, precision, and minimal surrounding tissue disturbance, making it ideal for facial nevi in areas such as the nasal tip or eyelid margin where tissue conservation is paramount.

PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (2–4 Weeks Before Travel)

• Patient submits dermoscopic photographs or clinical images through GAF Healthcare's secure telemedicine portal for remote assessment by a board-certified dermatologist or plastic surgeon.
• The treating physician provides a provisional classification (benign vs. atypical vs. suspicious) and recommends the appropriate excision technique and required pre-op investigations.
• GAF Healthcare's medical coordinator prepares a detailed cost estimate, treatment plan, and coordinates e-Medical Visa documentation for India or UAE entry visa facilitation.
• Pre-operative blood work (FBC, coagulation screen, HbA1c if diabetic) may be performed at the patient's home country and uploaded digitally to reduce time spent in the destination country.

PHASE 2 — Arrival & DAY-0 Consultation